ALLI (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the ALLI drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
NON-PROPRIETARY NAME: | orlistat |
SUBSTANCE NAME: | ORLISTAT |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2007-02-07 |
END MARKETING DATE: | 0000-00-00 |
ALLI HUMAN OTC DRUG Details:
Item Description | ALLI from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/1) |
START MARKETING DATE: | 2007-02-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0135-0461_65f531e7-7d98-448e-9c4b-497523b3b8f4 |
PRODUCT NDC: | 0135-0461 |
APPLICATION NUMBER: | NDA021887 |
Other ORLISTAT Pharmaceutical Manufacturers / Labelers: